Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe record history now adds 'No longer looking for participants' and updates the revision to v3.6.0. This indicates a new version of the study record and that enrollment has ended.SummaryDifference0.2%

- Check14 days agoChange DetectedThe revision label on the page updated from v3.5.4 to v3.5.5. This indicates a minor site maintenance or bug fix update rather than changes to the study records or visible content.SummaryDifference0.0%

- Check21 days agoChange DetectedA new version entry was added on 2026-05-28 with updates to Study Status and Contacts/Locations (version 66 indicated for 2026-05-27); the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision history updated to include a new entry labeled v3.5.4 and removed the previous v3.5.3 entry, indicating a backend revision to the documentation/versioning.SummaryDifference0.0%

- Check57 days agoChange DetectedThis updates the displayed software/site revision from v3.5.2 to v3.5.3 on the ClinicalTrials.gov record history page.SummaryDifference0.0%

- Check64 days agoChange DetectedA new revision entry v3.5.2 was added, and the previous revision v3.5.0 was removed from the page history.SummaryDifference0.0%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.